206697_CD Report_NNP &_CC Accounts_NNPS Back_RB 20_CD 3_CD 06_CD 7:46_CD pm_NN Page_NNP 120_CD NOTES_NNS TO_TO THE_DT EUROPEAN_NNP EMBEDDED_NNP VALUE_NNP BASIS_NNP continued_VBD The_DT main_JJ component_NN of_IN the_DT experience_NN variances_NNS is_VBZ the_DT use_NN of_IN brought-forward_JJ realized_VBN tax_NN losses_NNS ._.
This_DT has_VBZ increased_VBN the_DT IFRS_NNP net_JJ assets_NNS and_CC reduced_VBD the_DT value_NN of_IN the_DT tax_NN assets_NNS in_IN the_DT PVIF_NNP ._.
The_DT main_JJ components_NNS of_IN the_DT operating_NN assumption_NN changes_NNS are_VBP the_DT increases_NNS in_IN insurance_NN contract_NN liability_NN provisions_NNS due_JJ to_TO changes_NNS in_IN the_DT mortality_NN ,_, morbidity_NN and_CC expense_NN assumptions_NNS ._.
These_DT were_VBD allowed_VBN for_IN in_IN the_DT 2004_CD EEV_NNP PVIF_NNP and_CC have_VBP resulted_VBN in_IN a_DT transfer_NN from_IN PVIF_NNP to_TO net_JJ assets_NNS this_DT year_NN ._.
V._NNP EUROPEAN_NNP EMBEDDED_VBD VALUE_NN SENSITIVITIES_NNS The_DT table_NN below_IN shows_NNS the_DT estimated_JJ impact_NN on_IN the_DT combined_VBN life_NN and_CC unit_NN trust_NN reported_VBD value_NN of_IN new_JJ business_NN and_CC EEV_NNP to_TO changes_NNS in_IN various_JJ EEV_NNP calculated_VBN assumptions_NNS ._.
In_IN each_DT case_NN ,_, only_RB the_DT indicated_VBN item_NN is_VBZ varied_VBN relative_JJ to_TO the_DT restated_VBN values_NNS ._.
Change_NNP in_IN new_JJ business_NN contribution_NN Change_NNP in_IN European_NNP Emedded_NNP Value_NNP Pre-tax_NNP Post-tax_NNP Post-tax_NNP Note_VB Million_NNP Million_NNP Million_NNP Value_NNP at_IN 31_CD December_NNP 2005_CD 67.2_CD 48.5_CD 828.8_CD 100bp_JJ reduction_NN in_IN risk_NN discount_NN rate_NN 1_CD 13.0_CD 9.4_CD 51.2_CD 100bp_JJ reduction_NN in_IN risk_NN free_JJ rates_NNS ,_, with_IN corresponding_JJ change_NN in_IN fixed_JJ interest_NN asset_NN values_NNS 3.0_CD 2.1_CD 2.6_CD 10_CD %_NN reduction_NN in_IN withdrawal_NN rates_NNS 8.4_CD 6.1_CD 35.0_CD 10_CD %_NN reduction_NN in_IN expenses_NNS 10.0_CD 7.3_CD 12.1_CD 10_CD %_NN reduction_NN in_IN market_NN value_NN of_IN equity_NN assets_NNS n_VBP a_DT n_NN a_DT 53.6_CD 5_CD %_NN reduction_NN in_IN mortality_NN and_CC morbidity_NN 2_CD 0.6_CD 0.4_CD 3.5_CD 100bp_JJ increase_NN in_IN equity_NN expected_VBN returns_NNS 3_LS -_: -_: -_: Note_NN 1_CD :_: Although_IN not_RB directly_RB relevant_JJ under_IN a_DT market-consistent_JJ valuation_NN where_WRB the_DT risk_NN discount_NN rate_NN is_VBZ a_DT derived_VBN disclosure_NN only_RB ,_, this_DT sensitivity_NN shows_VBZ the_DT level_NN of_IN adjustment_NN which_WDT would_MD be_VB required_VBN to_TO reflect_VB differing_VBG investor_NN views_NNS of_IN risk_NN ._.
Note_VB 2_CD :_: Assumes_VBZ the_DT benefit_NN of_IN lower_JJR experience_NN is_VBZ passed_VBN on_IN to_TO clients_NNS and_CC reassurers_NNS at_IN the_DT earliest_JJS opportunity_NN ._.
Note_VB 3_CD :_: As_IN a_DT market-consistent_JJ approach_NN is_VBZ used_VBN ,_, equity_NN expected_VBN returns_NNS only_RB affect_VBP the_DT derived_VBN discount_NN rates_NNS and_CC not_RB the_DT embedded_VBN value_NN or_CC contribution_NN to_TO profit_VB from_IN new_JJ business_NN ._.
